JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
2601
Balchem Corp
BCPC
$5.65B
| $4.76M | ﹤0.01% |
46,859
+17,968
| +62% | +$1.81M |
|
2602
CALL
Peloton Interactive
PTON
$2.44B
| $4.75M | ﹤0.01% |
+167,100
| New | +$4.5M |
|
2603
Par Pacific Holdings
PARR
$4.12B
| $4.74M | ﹤0.01% |
204,177
-957
| -0.5% | -$22.8K |
|
2604
Arcus Biosciences
RCUS
$3.67B
| $4.73M | ﹤0.01% |
468,364
-43,000
| -8% | -$362K |
|
2605
Ryder
R
$10.1B
| $4.73M | ﹤0.01% |
87,046
-71,202
| -45% | -$3.7M |
|
2606
iShares US Healthcare ETF
IYH
$3.77B
| $4.72M | ﹤0.01% |
109,500
-66,325
| -38% | -$2.68M |
|
2607
Orion
OEC
$364M
| $4.71M | ﹤0.01% |
244,269
+45,120
| +23% | +$815K |
|
|
MNR
2608
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $4.71M | ﹤0.01% |
325,544
+102,890
| +46% | +$1.52M |
|
2609
GATX Corp
GATX
$6.34B
| $4.71M | ﹤0.01% |
56,789
+79
| +0.1% | +$6.36K |
|
|
COHR
2610
DELISTED
Coherent Inc
COHR
| $4.71M | ﹤0.01% |
28,283
-1,359
| -5% | -$210K |
|
2611
Neurocrine Biosciences
NBIX
$15.9B
| $4.69M | ﹤0.01% |
43,634
+12,023
| +38% | +$1.26M |
|
2612
iShares Europe ETF
IEV
$1.7B
| $4.69M | ﹤0.01% |
99,891
+4,793
| +5% | +$215K |
|
|
DMC
2613
Del Monte Corp
DMC
$1.42B
| $4.69M | ﹤0.01% |
133,997
-83,003
| -38% | -$2.66M |
|
2614
Myers Industries
MYE
$1.23B
| $4.68M | ﹤0.01% |
280,607
-13,387
| -5% | -$223K |
|
2615
CALL
Adient
ADNT
$1.44B
| $4.67M | ﹤0.01% |
220,000
-129,700
| -37% | -$2.88M |
|
|
SC
2616
CALL
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $4.67M | ﹤0.01% |
200,000
| – | – |
|
|
SC
2617
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $4.67M | ﹤0.01% |
200,000
| – | – |
|
2618
FirstService
FSV
$6.24B
| $4.67M | ﹤0.01% |
50,185
-40,366
| -45% | -$3.8M |
|
2619
CALL
Goodyear
GT
$1.78B
| $4.67M | ﹤0.01% |
300,000
| – | – |
|
|
INVX
2620
Innovex International
INVX
$2.15B
| $4.66M | ﹤0.01% |
99,327
-547,671
| -85% | -$25.1M |
|
2621
PUT
Omeros
OMER
$1.26B
| $4.66M | ﹤0.01% |
330,600
+105,500
| +47% | +$1.54M |
|
|
SCWX
2622
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $4.65M | ﹤0.01% |
279,257
+199,054
| +248% | +$2.57M |
|
2623
American Superconductor
AMSC
$1.53B
| $4.64M | ﹤0.01% |
591,615
+489,469
| +479% | +$3.94M |
|
2624
CALL
Archer Daniels Midland
ADM
$38.6B
| $4.63M | ﹤0.01% |
100,000
| – | – |
|
|
RESI
2625
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $4.63M | ﹤0.01% |
375,544
-149,739
| -29% | -$1.78M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.